Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Inpatient Hospitalization's Associated Cost and Mortality for Myeloma Patients Undergoing Autologous Stem Cell Transplant: A 13-Year Analysis of the National Inpatient Sample

Saqib Abbasi, MD, Brian McClune, DO, Leyla Shune, MD, Suman Kambhampati, MD, Saqib Abbasi, MD

Blood (2019) 134 (Supplement_1): 3431.

https://doi.org/10.1182/blood-2019-131622

Published: 2019

Journal Articles

Conditioning Regimen Intensity May Affect Outcome in MDS Patients Undergoing Allogeneic Stem Cell Transplantation, Depending on MDS Subgroup

Barry S. Skikne, MD, Anurag K. Singh, MD, Sunil Abhyankar, MD, Tara L. Lin, MD, Leyla Shune, MD, Neil Dunavin, MD, Ajoy L. Dias, MD, Brian McClune, DO, Abdulraheem Yacoub, MD, Clint Divine, Haitham Abdelhakim, MD, Siddhartha Ganguly, MD, Jennifer Hanses, Carol E Webb, BA, Joseph P. McGuirk, DO

Blood (2019) 134 (Supplement_1): 5743.

https://doi.org/10.1182/blood-2019-130828

Published: 2019

Journal Articles

Maintenance and Consolidation Regimens after a Second Autologous Transplant for Multiple Myeloma: A Decade of Experiences

Ghulam Rehman Mohyuddin, MD, Maire Okoniewski, Osama Diab, MD, Siddhartha Ganguly, MD, Al-Ola Abdallah, MD, Leyla Shune, MD, Joseph P. McGuirk, DO, Brian McClune, DO

Blood (2019) 134 (Supplement_1): 5700.

https://doi.org/10.1182/blood-2019-130619

Published: 2019

Journal Articles

Daratumumab, Pomalidomide, and Dexamethasone (DPd) As Salvage Treatment for Relapsed/Refractory Myeloma Eligible for High-Dose Chemotherapy/Autologous Stem Cell Transplantation

Al-Ola Abdallah, MD, Neil Dunavin, MD, Brian McClune, DO, Leyla Shune, MD, Ajoy L. Dias, MD, Zahra Mahmoudjafari, PhD, Erica Hochard, PhD, Joseph P. McGuirk, DO, Siddhartha Ganguly, MD

Blood (2018) 132 (Supplement 1): 5760.

https://doi.org/10.1182/blood-2018-99-117654

Published: 2018

Journal Articles

Daratumumab, Pomalidomide, and Dexamethasone (DPd) for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Institution Experience

Al-Ola Abdallah, MD, Neil Dunavin, MD, Brian McClune, DO, Leyla Shune, MD, Ajoy L. Dias, MD, Zahra Mahmoudjafari, PhD, Erica Hochard, PhD, Joseph P. McGuirk, DO, Siddhartha Ganguly, MD

Blood (2018) 132 (Supplement 1): 5642.

https://doi.org/10.1182/blood-2018-99-117497

Published: 2018

Journal Articles

Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation

Livia Hegerova, MD, Adam Bachan, Qing Cao, MS, Veronika Bachanova, MD PhD, Mark Reding, MD, John Rogosheske, PharmD, Brian McClune, DO, Aleksandr Lazaryan, MD PhD MPH, Greg M Vercellotti, MD FACP, Huong X Vu, PharmD

Blood (2017) 130 (Supplement 1): 3695.

https://doi.org/10.1182/blood.V130.Suppl_1.3695.3695

Published: 2017

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Elderly Patients: Prognosis Determined By Disease Risk Index

Fiona C. He, MD, Aleksandr Lazaryan, MD PhD MPH, Qing Cao, M.S., Claudio G Brunstein, MD, Shernan G. Holtan, MD, Erica D. Warlick, MD, Celalettin Ustun, MD, Brian McClune, DO, Mukta Arora, MD, Daniel J. Weisdorf, MD, Nelli Bejanyan, MD

Blood (2016) 128 (22): 2305.

https://doi.org/10.1182/blood.V128.22.2305.2305

Published: 2016

Journal Articles

Comparison of Autologous Hematopoietic Cell Transplant (autoHCT), Bortezomib, Lenalidomide (Len) and Dexamethasone (RVD) Consolidation with Len Maintenance (ACM), Tandem Autohct with Len Maintenance (TAM) and Autohct with Len Maintenance (AM) for up-Front Treatment of Patients with Multiple Myeloma (MM): Primary Results from the Randomized Phase III Trial of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0702 - StaMINA Trial)

Blood (2016) 128 (22): LBA-1.

https://doi.org/10.1182/blood.V128.22.LBA-1.LBA-1

Published: 2016

Journal Articles

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies

Yi-Bin Chen, MD, Jennifer Le-Rademacher, PhD, Deidre Marie Kiefer, MPH, Mehdi Hamadani, MD, John F. DiPersio, MD PhD, Mark R Litzow, MD, Michael Craig, MD, Mitchell E. Horwitz, MD, Andrew Artz, MD MS, Brian McClune, DO, Edmund K Waller, MD PhD, Hugo F. Fernandez, MD, Hien Kim Duong, MD, Hati Kobusingye, Mandi Proue, MPH, Rebecca J. Drexler, MPH, Mary M. Horowitz, MD MS, John P. Miller, MD PhD, Steven M. Devine, MD

Blood (2015) 126 (23): 389.

https://doi.org/10.1182/blood.V126.23.389.389

Published: 2015

Journal Articles

Transplantation Related Toxicity and Mortality in Older Autologous Hematopoietic Cell Transplantation Recipients

Hewan Belete, MDcal student, Linda J. Burns, MD, Ryan Shanley, MS, Manju Nayar, MBBS, Brian McClune, DO, Nishant Sahni, MDMS, Aleksandr Lazaryan, MD PhD, Veronika Bachanova, MD, Daniel J. Weisdorf, MD, Mukta Arora, MD MS

Blood (2014) 124 (21): 3965.

https://doi.org/10.1182/blood.V124.21.3965.3965

Published: 2014

Journal Articles

Chemo-Mobilization Provides Superior Mobilization and Collection in Autologous Stem Cell Transplants but with Less Predictability and At a Higher Cost,

Nelson J. Chao, MD, Daniel T Grima, M.Sc., George Carrum, MD, Leona Holmberg, MD., PhD, Henry C. Fung, FRCP, MD, Stephen Brown, Ph.D., Mitchell E. Horwitz, MD, Lisa M Bernard, M.Sc., Junya Kanda, MD, Jane L. Liesveld, MD, Brian McClune, DO, Paul Shaughnessy, MD, Guido J. Tricot, MD, PhD

Blood (2011) 118 (21): 4048.

https://doi.org/10.1182/blood.V118.21.4048.4048

Published: 2011

Journal Articles

Differences in Stem Cell Collection Practices and Related Outcomes Between Centers That Conduct and Do Not Conduct Aphaeresis on Weekends

Nelson J. Chao, MD, Lisa M Bernard, M.Sc., George Carrum, MD, Henry C. Fung, FRCP, MD, Daniel T Grima, M.Sc., Leona Holmberg, MD., PhD, Stephen Brown, Ph.D., Mitchell E. Horwitz, MD, Junya Kanda, MD, Jane L. Liesveld, MD, Brian McClune, DO, Paul Shaughnessy, MD, Guido J. Tricot, MD, PhD

Blood (2011) 118 (21): 1925.

https://doi.org/10.1182/blood.V118.21.1925.1925

Published: 2011

Journal Articles

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

Brian McClune, DO, Tanya L. Pedersen, MPH, Kwang W Ahn, PhD, Erica D Warlick, MD, Joseph Pidala, MD, MS, Edmund K Waller, MD PhD, J. Douglas Rizzo, MD MS, Mitchell S. Cairo, MD, Ann Woolfrey, MD, Andrew Artz, MD MS, Hillard M. Lazarus, MD FACP, Daniel J. Weisdorf, MD

Blood (2011) 118 (21): 1015.

https://doi.org/10.1182/blood.V118.21.1015.1015

Published: 2011

Journal Articles

Older Adults with Chronic Myelogenous Leukemia (CML), During the Tyrosine Kinase Inhibitor (TKI) Era, Can Be Successfully Treated with Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplant (HCT) Using Sibling or Unrelated Donors: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Erica D Warlick, MD, Brian McClune, DO, Tanya L. Pedersen, MPH, Kwang W Awn, PhD, Joseph H. Antin, MD, Jean-Yves Cahn, MD, Marcos DeLima, MD, Vikas Gupta, MD, FRCP, FRCPath, David I Marks, MD, Donald Bunjes, MD, John F. DiPersio, MD, PhD, Steven Devine, Daniel J. Weisdorf, MD

Blood (2011) 118 (21): 494.

https://doi.org/10.1182/blood.V118.21.494.494

Published: 2011

Journal Articles

Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: Similar Efficacy of Non-Myeloablative and Myeloablative Conditioning; Long-Term Evaluation From the University of Minnesota.

Brian McClune, DO, Linda J. Burns, MD, Todd E. DeFor, MS, Arne Slungaard, MD, Veronika Bachanova, Claudio Brunstein, MD, PhD, Daniel J. Weisdorf

Blood (2009) 114 (22): 3385.

https://doi.org/10.1182/blood.V114.22.3385.3385

Published: 2009

Journal Articles

Non-Myeloablative Hematopoietic Stem Cell Transplantation in Older Patients with AML and MDS: Results from the Center for International Blood and Marrow Transplant Research (CIBMTR)

Brian McClune, DO, Daniel J. Weisdorf, MD, John F. DiPersio, MD, PhD, Armand Keating, MD, Tanya L. Pedersen, Gisela Tunes da Silva, PhD., J. Sierra, MD, Martin S. Tallman, MD, Sergio A. Giralt

Blood (2008) 112 (11): 346.

https://doi.org/10.1182/blood.V112.11.346.346

Published: 2008

Journal Articles

Encouraging Results of Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation for the Treatment of Advanced Lymphoid Malignancies.

Claudio G. Brunstein, MD, Susana Cantero, MD, Qing Cao, MS, Navneet Majhail, MD, Brian McClune, DO, Linda J. Burns, MD, Marcie Tomblyn, MD, Jeffrey S. Miller, MD, Bruce R. Blazar, MD, Philip B. McGlave, MD, Daniel J. Weisdorf, MD, John E. Wagner, MD

Blood (2007) 110 (11): 2028.

https://doi.org/10.1182/blood.V110.11.2028.2028

Published: 2007

Journal Articles

Oral Voriconazole for Empiric Antifungal Treatment in Uncomplicated Febrile Neutropenic Patients.

Kara Keasler, PharmD, Joyce Broyles, Pharm.D., Brian McClune, DO, Francis Buadi, MD, Donna Przepiorka, MD, PhD

Blood (2006) 108 (11): 5494.

https://doi.org/10.1182/blood.V108.11.5494.5494

Published: 2006

Journal Articles

Myelodysplasia after Autologous Stem Cell Transplantation for Multiple Myeloma.

Gregory Franz, MD, Brian McClune, DO, Francis Buadi, MD, William Walsh, MD, Frank White, MD, Donna Przepiorka, MD, PhD

Blood (2006) 108 (11): 5329.

https://doi.org/10.1182/blood.V108.11.5329.5329

Published: 2006

Journal Articles

Intrathecal Liposomal Cytarabine (Depocyt) Is Safe and Effective for Prevention of Meningeal Disease in Patients with Acute Lymphoblastic Leukemia and High-Grade Lymphoma Treated with the HyperCVAD Regimen.

Brian McClune, DO, Francis Buadi, MD, Naveed Aslam, MD, Donna Przepiorka, MD, PhD

Blood (2005) 106 (11): 4594.

https://doi.org/10.1182/blood.V106.11.4594.4594

Published: 2005

NARROW

Inpatient Hospitalization's Associated Cost and Mortality for Myeloma Patients Undergoing Autologous Stem Cell Transplant: A 13-Year Analysis of the National Inpatient Sample

Conditioning Regimen Intensity May Affect Outcome in MDS Patients Undergoing Allogeneic Stem Cell Transplantation, Depending on MDS Subgroup

Maintenance and Consolidation Regimens after a Second Autologous Transplant for Multiple Myeloma: A Decade of Experiences

Daratumumab, Pomalidomide, and Dexamethasone (DPd) As Salvage Treatment for Relapsed/Refractory Myeloma Eligible for High-Dose Chemotherapy/Autologous Stem Cell Transplantation

Daratumumab, Pomalidomide, and Dexamethasone (DPd) for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Institution Experience

Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation

Allogeneic Hematopoietic Cell Transplantation for Elderly Patients: Prognosis Determined By Disease Risk Index

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies

Transplantation Related Toxicity and Mortality in Older Autologous Hematopoietic Cell Transplantation Recipients

Chemo-Mobilization Provides Superior Mobilization and Collection in Autologous Stem Cell Transplants but with Less Predictability and At a Higher Cost,

Differences in Stem Cell Collection Practices and Related Outcomes Between Centers That Conduct and Do Not Conduct Aphaeresis on Weekends

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: Similar Efficacy of Non-Myeloablative and Myeloablative Conditioning; Long-Term Evaluation From the University of Minnesota.

Non-Myeloablative Hematopoietic Stem Cell Transplantation in Older Patients with AML and MDS: Results from the Center for International Blood and Marrow Transplant Research (CIBMTR)

Encouraging Results of Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation for the Treatment of Advanced Lymphoid Malignancies.

Oral Voriconazole for Empiric Antifungal Treatment in Uncomplicated Febrile Neutropenic Patients.

Myelodysplasia after Autologous Stem Cell Transplantation for Multiple Myeloma.

Intrathecal Liposomal Cytarabine (Depocyt) Is Safe and Effective for Prevention of Meningeal Disease in Patients with Acute Lymphoblastic Leukemia and High-Grade Lymphoma Treated with the HyperCVAD Regimen.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only